Objective: This study was undertaken to evaluate transit-time flow (TTF) as a tool to detect technical errors in arterial bypass grafts intraoperatively and predict outcomes. Methods: TTF's three parameters, pulsatility index (PI, index of resistance), flow (cc min À1 ) and diastolic filling (DF, proportion of diastole with coronary flow), were measured in 990/1000 (99%) of arterial grafts in 336 consecutive patients, prospectively enrolled in a database. Grafts were revised when TTF findings supported the otherwise suspected graft malfunction. If no other signs/suspicion of graft malfunction existed (normal electrocardiogram (EKG), stable haemodynamics and unchanged ventricular function on trans-oesophageal echocardiography (TEE)), and the PI was >5, grafts were not revised. Major adverse cardiac events (MACEs: recurrent angina, perioperative myocardial infarction, postoperative angioplasty, re-operation and/or perioperative death) were related to TTF measurements. Results: The average number of grafts per patient was 3.02, of which 99% were arterial. Satisfactory grafts were achieved in 916/990 (93%) of the grafts, with flows from 34 to 61 cc min
Introduction
Early postoperative graft failure following coronary artery bypass graft (CABG) surgery is associated with high morbidity and mortality [1] [2] [3] [4] . Surgeons generally rely on finger palpation assessment of the pulse in the bypass graft; recent data suggest that only 20% of cardiac surgeons in North America use transit-time flow (TTF) measurement to assess grafts. 1 It is well established that arterial grafting with internal thoracic arteries confers long-term benefit [5] [6] [7] ; a reliable method to assess graft function before completing the operation could potentially improve outcomes. There are no published studies of this size evaluating TTF in a pure series of arterial grafts.
In the present study, we used TTF in 336 consecutive patients to assess the value of this method in predicting postoperative major adverse cardiac events (MACEs). Our findings suggest that the pulsatility index (PI), one of three TTF measurements, is highly predictive of outcomes.
Materials and methods
This study is a retrospective analysis of data from consecutive patients of a single surgeon in whom TTF was first used in our institution for bypass graft assessment intraoperatively. Beginning April 2004, TTF was used in all but three patients (with 10 grafts for whom the equipment was either in use or not functioning) until the number of 1000 consecutive arterial grafts were reached (April 2007) . This study was submitted to our institutional Research Ethics Board and individual patient consent was waived.
Surgical details
Intermittent antegrade warm blood for myocardial protection and systemic hypothermia at 32 8C were used. Internal thoracic conduits were harvested in a skeletonised E-mail address: t.kieserprieur@ucalgary.ca (T.M. Kieser). 1 Milstein H. Introductory Letter Graft Patency.com. manner using a harmonic scalpel. Radial artery conduits were harvested in a non-skeletonised manner, also with a harmonic scalpel. High spinal anaesthesia (local anaesthetic and opioid) supplemented by light general anaesthesia was used; intra-operative trans-oesophageal echocardiography (TEE) was also used except where contraindicated. Patients with radial artery conduits received long-acting nitrates for 6 weeks to prevent arterial spasm.
TTF assessment
TTF measurement provides three parameters: PI, mean flow and diastolic filling (DF). Abnormal values for bypass grafts for these three parameters used in this study were as follows: PI >5, flow <15 cc min À1 and DF <25. A PI value 5, as recommended by the manufacturer (MediStim Oslo, Norway), 2 was chosen as the principal measure of graft adequacy. The cut-off value for flow has not yet been defined in the literature and was defined as <15 cc min À1 to be consistent with that used in several previous studies [9] [10] [11] [12] . Similarly for DF, an optimal cut-point has not been clarified and, therefore, after consultation with MediStim personnel, it was defined as <25, 3 a value well below the accepted range of 45-80 recommended by the manufacturer. 4 The measurements were performed three times for each graft -after removal of the cross-clamp with a beating heart, off-pump before protamine and then off-pump after protamine administration. Only the post-protamine value was used for the present analysis. Probe sizes were selected to match the largest arterial conduit, skeletonising a small portion of the radial artery when necessary. Grafts were revised if a poorly functioning graft was suspected employing usual clinical criteria (electrocardiogram (EKG) changes, haemodynamic instability and new regional wall motion abnormalities on TEE). For the most part, if the TTF values alone indicated a poor graft, the grafts were not revised. Occasionally, a graft was revised if the TTF value was surprisingly abnormal or corroborated the suspicion of a poor graft. Individual graft measurement for sequential grafts was done whenever possible by measuring the whole graft and the 'in-between segment'. This was usually only possible for grafts on the anterior surface of the heart (left anterior descending coronary artery (LAD) region) because the necessary displacement of the heart (causing blood pressure (BP) drop) precluded measurement of this segment in sequential grafts to the posterior and inferior regions of the left ventricle. Perioperative mortality was defined as death within 30 days of surgery or during the same hospitalisation if it was longer.
Data collection
All patients were entered at the time of initial cardiac catheterisation into a provincial database (APPROACH: Alberta Provincial Program for Outcome Assessment in Coronary Heart disease) [8] . APPROACH is an ongoing prospective data collection initiative in the province of Alberta in which patients are followed up long term to assess outcomes. Patients were seen 6-8 weeks postoperatively by the operating surgeon and the mean follow-up was 3 years.
Statistical analysis
Continuous variables are expressed using the median and interquartile range since the distributions were highly skewed. Exact binomial 95% confidence intervals (CIs) were calculated for proportions. The data of two independent groups were compared by Fisher's exact test (FET). Initially, a univariate logistic regression analysis was done for each of the potential predictor variables of MACE. Variables that were significant at p < 0.10 were also included in a multivariate regression model. Statistical analyses were performed using Stata.8.0 (StataCorp, College Station, TX, USA). A p value of <0.05 was considered to be statistically significant.
Results

TTF measurements
Demographics of the patient population are shown in Table 1 . A total of 336 consecutive patients had 1015 grafts, of which 1000 were arterial. TTF was used to measure flow in 990 (99%) of the grafts, which included single (grafts with only one distal anastomoses), sequential (grafts with one or more side-to side and one end-to-side anastomoses) and composite (grafts with two separate conduits joined to make 'Y' or 'T' graft) left internal thoracic arteries (LITAs), single and sequential right internal thoracic arteries (RITAs), single and sequential radial arteries and single inferior epigastric arteries (Table 2) . Fifteen primary vein grafts were used and five arterial grafts were replaced with saphenous veins at a second emergent operation in four patients (one of the five arterial grafts had a PI >5). Sequential grafts comprised 111/ 323 (34%) of LITA conduits and 66/239 (28%) of radials. Of the 1000 arterial grafts, 693 (69%) were internal thoracic arteries, and 234/336 patients (70%) of the patients had bilateral internal thoracic artery (BITA) grafts. Almost all the operations were on-pump (95%); off-pump was done either a In-patient -patient considered too unstable to be discharged home before undergoing surgery.
for single grafts or in patients with a calcified ascending aorta.
Satisfactory grafts were those grafts with a PI 5. Suboptimal grafts were those grafts with a PI of >5. As many as 916 of the 990 grafts assessed (93%) were deemed satisfactory (a PI value 5). The remaining 74 grafts (7%) with a PI value >5 occurred in 59 of the 336 patients (18%). None of the patients in the latter group showed any other signs of graft malfunction, such as EKG changes, regional wall motion abnormalities on TEE or haemodynamic compromise. Table 3 shows the TTF values for the grafts deemed satisfactory and Table 4 shows the values for the grafts deemed suboptimal.
As seen in Table 3 (satisfactory grafts), the mean PI values for the individual conduits ranged from 1.7 to 3.1 and the DF values from 62% to 73%. Median flow in the major single conduits (LITA, RITA and radial) was 39, 32 and 34 cc min À1 , respectively (average 35 cc min À1 ). In the sequential grafts (LITA, RITA and radial), the median flow was 43, 45.5 and 42 cc min À1 , respectively (average 43.5 cc min À1 ), and the composite grafts had the highest median flow (54 cc min À1 ). We found that sequential grafts had greater flow than single conduits and when these 'in-between segments' were in a technically easy accessible location to measure, the individual components could be evaluated. Flow in the sequential grafts was 1.24 times higher, and flow in the composite grafts was 1.5 times higher than flow in single conduits. For the measured sequential LITA grafts, one coronary artery territory was served by the majority of the sequential conduits (107/110, 97%), whereas two coronary artery territories were served by composite grafts in the majority of cases (21/23 grafts, 91%). Table 4 shows the TTF parameters for the suboptimal grafts: for all types of grafts, the median PI was higher ranging from 5.8 for the sequential radial grafts to 8.8 for the single radial grafts. The single RITA group had the highest number of grafts with a PI >5. (14.2% compared with 3.7% single LITAs, 5.5% sequential LITAs, 4.3% composite LITAs, 0% sequential RITAs, 7.7% single radial grafts, 4.6% sequential radial grafts and one of two IEAs (Inferior Epigastric Arteries)). Fig. 1(a) and (b) shows examples of TTF values of a good and suboptimal graft, respectively. 
Intra-operative revisions
Fifteen conduits in 14 patients, responsible for 20 grafts (2%), were revised. Simple corrections were required in five grafts (four conduits) by preventing twisting of the graft or tendency to flip, by incision of an obstructing pericardial edge or by correcting spasm. Ten conduits responsible for 15 grafts required major revisions: redo distal anastomosis (four conduits, five grafts), direct attachment of conduit to aorta or another conduit (seven conduits, nine grafts), endarterectomy (one conduit, one graft) or replace with a vein (one conduit, two grafts). (Some patients required more than one type of revision.) Most of the revisions (19/20) were performed before protamine administration: five grafts after the first TTF measurements (on-pump, cross-clamp off), 14 grafts when a problem was noticed off-pump and one revision was required after protamine administration. The decision was made to revise when other signs of graft malfunction occurred (abnormal wall motion on TEE in two patients and ventricular fibrillation in one patient), when all three TTF parameters suggested an unanticipated poorly functioning graft (eight patients) or when there was a high index of suspicion that the graft was not good and was associated with poor TTF parameters (three patients). After revision, PI improved in 17 of the 20 grafts and 16 of the 17 grafts had an improved PI to a value <5. The TTF values listed were for the revised grafts.
Major adverse cardiac events
Twenty-five (7.4%) patients suffered 41 (95% CI 4.9-1.8%) MACEs postoperatively -recurrent angina: 6/336 (1.8%), perioperative myocardial infarction: 9/336 (2.7%), percutaneous coronary intervention (PCI): 6/336 (1.8%), early reoperation (no late re-operations): 4/336 (1.2%) and/or perioperative death: 16/336 (4.8%). Excluding emergency operations (patients requiring surgery within 24 h of known requirement for surgery), operative mortality was 3.3%. MACE occurred in 10/59 (17%) of those patients with at least one bypass graft with a PI value >5, and in 15/277 (5.4%) of those with a PI 5 for all bypasses ( p = 0.005). Excluding 32 emergency operations from these two groups (two deaths out of the five with a high PI, and four deaths out of the 27 with a low PI), there were still significantly more deaths in the high PI group: 5/54 (11%; 95% CI 4.4-23.4) compared to 5/250 (2%; 95% CI 0.4-4.0 patients in the low PI group ( p = 0.02).
A flow value <15 cc min À1 and a DF value of <45 did not predict MACE, including cardiac death, with the possible exception of a mortality difference using DF to assess graft function only after emergency cases were excluded ( Table 5) .
The variables PI >5, age (per 10 years) and admission status were all significant predictor variables of MACE at p < 0.05. No other variable was significant at p < 0.10 and, therefore, no other variables were included in the multivariate regression analysis. All three variables were independent significant predictors of MACE in the multivariate regression model. Note that although the variables were significant, the CIs are wide due to the small number of MACE. The multivariate logistic regression model showed that PI >5 was a significant predictor of MACE (odds ratio (OR) = 4.23, 95% CI 1.7-10.6, p = 0.002) after controlling for admission status, that is, for a given admission status and age, the risk of MACE was 4.2 times higher when the PI >5 (Table 6 ). We examined in detail the 10 patients with high PI values in at least one graft that also suffered MACEs and related the territory of the high PI graft to the territory causing angina, PCI and myocardial infarction. In seven of these 10 patients, there was a direct correlation: three with angina (one went on to have PCI) had verification to the same territory with regular angiography (1), computed tomography (CT) angio (1) and thallium (1) . In four patients with perioperative myocardial infarction, one of whom needed emergency reoperation (all four died), the infarct was in the territory supplied by the artery with the high PI, verified by the EKG changes (2), echo changes (1) and re-operative findings (1). In the three remaining patients, although the PI was high (5.2, 6.3 and 6.9) the flows were reasonable or good (17, 42 and 64 cc min À1 ), and the cause of death was non-cardiac (sepsis and cerebrovascular accident (CVA) (1), autopsy-documented CVA with patent bypasses (1) and intra-abdominal catastrophe (1)).
Discussion
In this study of 336 consecutive patients who had CABG surgery with almost exclusively arterial grafts, we have shown that the PI obtained by TTF measurement is a strong predictor of clinical outcomes, whereas flow and DF measurements were not. Thus, those patients with at least one graft with a PI value >5 were more than four times more likely to suffer an MACE postoperatively. In addition, if the operation was non-emergent, the mortality was four times higher if the PI >5. Thus, our study directly links MACEs, including operative mortality with grafts predicted, to be malfunctioning by TTF.
Several authors have also correlated adverse events with abnormal intra-operative TTF measurements. Herman et al. [13] , in a study of 985 cardiac surgery patients with both arterial and venous conduits, found abnormal grafts (PI > 5) in 19% of patients; this group suffered significantly more events compared with the normal PI group (31% vs 17%, p < 0.0001). However, in-hospital mortality did not correlate with abnormal grafts. Becit et al. [14] compared 100 patients with 40% arterial and 60% venous grafts, before starting to use TTF with a subsequent 100 patients in whom TTF was first used; there were more adverse events in the pre-TTF patient group. Poorly functioning bypass grafts are known to be associated with postoperative morbidity and mortality. Weman et al. [4] reported that 54.7% of 223 patients who died early after CABG surgery had gross technical problems in the bypasses (unrecognised twisted conduits, stenotic anastomoses and dissections).
Using the PI to assess intra-operative graft function is simple and takes little time. This is especially important in on-pump surgery where at least three measurements are optimal; with serial measurements, a surgeon can be alerted to the presence of a poorly functioning graft before the more complex-to-reverse steps in an operation, such as coming offpump or administering protamine.
The cut-off value of 5 for an optimal graft is suggested by the manufacturer; some authors have chosen a PI <3 as an indicator of a good graft [9, 10] . Grafts with a PI value between 3 and 5 may not necessarily indicate poor graft function because parameters such as competitive flow or diffuse disease of the grafted artery can also increase resistance. Competitive flow can be assessed by snaring the native coronary proximal to the anastomosis. If neither significant competitive flow nor diffuse disease exists and the PI is suboptimal (3) (4) (5) , the graft may require revision. In this study, 93% of grafts had a PI 5; 78% (775/990) had a PI of <3.0. The authors devised an algorithm for decision making based on our experience and that of others (Fig. 2) . However, we do not suggest that every graft with a PI of !5 must be revised. Rather, a high PI should serve as an indicator that the graft should be re-assessed and that revision may be appropriate. Sometimes a minor twist or an obstructing pericardial edge is easily reparable and improvement can be confirmed with a quick second TTF measurement. Competitive flow, for example, may cause an elevated PI value of 6-7; however, in this case, usually the flow is good (>15 cc min À1 ). This could possibly be the case in the three patients with high PI and non-cardiac cause of death discussed in the previous paragraph.
A PI value may be elevated in very long arterial conduits because resistance to blood flow is determined by, among other factors, vessel length. This may not indicate poor graft function. In this study, the in situ RITA group, mostly going through the transverse sinus to a marginal artery (67% of the RITAs went to circumflex system), had the highest number of grafts with a high PI (14.2% vs 5.5% average for the single, sequential, composite LITA, single and sequential radial) - we suspect that the necessarily greater length of conduits may explain higher PI values in this group. Several authors have commented on the difficulty in assessing TTF in sequential grafts and have not included them in their studies [10, 11] . However, sequential grafting is an important feature of total arterial grafting -in this study 37% (371/1000 grafts) were sequential. We found that if one could measure the 'in-between-segment', the flow is almost always less and the PI higher when compared with total graft flow. In this manner, the individual components of a sequential graft can be assessed.
Flow did not prove to be a good indicator of graft function. It is dependent on many factors, including size, length and quality of conduit and native artery, run-off quality of coronary bed, mean arterial pressure, heart rate, competitive flow, viscosity of the blood and quality of distal AE proxproximal anastomoses. Some authors have controlled one factor, such as mean BP, with inotropic agents when measuring flow [10] [11] [12] . As flow is affected by so many variables, we chose not to standardise mean BP, which in our patients ranged from 60 to 70 mmHg. Several authors [9] [10] [11] [12] have suggested that a flow of <15 cc min À1 may signal a poor graft. In this study, a flow of <15 cc min À1 did not correlate with either postoperative death or MACE. Moreover, in those patients who underwent angiography, many with clinical indications, initial low flow values recorded at the time of surgery, did not appear to predict patent (n = 7, mean flow of 10.6 cc min À1 ) or occluded or compromised grafts (n = 5, mean flow of 9 cc min À1 ). Others have had similar findings: Shin et al. [15] observed that in LITA grafts, decreased graft flow with an acceptable PI correlated with vasospasm and not anastomotic problems. Hirotani et al. [16] found that mean flow in ITA grafts was greater than that in saphenous vein grafts and correlated significantly with the size of the territory being supplied by the graft.
As can be seen in Table 5 , DF appears to be a significant predictor of MACE in the non-emergency group of patients. Although it is possible that this finding is significant, we are concerned that, for several reasons, this may be just incidental -there were multiple comparisons; the significant p value was achieved only when emergency patients were excluded and this is the least well-defined cut-point of all three TTF parameters. (This value was recommended by the manufacturers; there is no research data to support this cutpoint). Furthermore, the DF data are incomplete (9% missing) because the EKG trace (on which the DF depends) was not always satisfactory. This remains an open question, and should be addressed in further studies.
Conclusions
The PI, obtained by TTF measurement, is a valuable tool to assess adequacy of arterial grafts and predict outcomes. Postoperative adverse events, especially operative mortality, are significantly higher in patients with grafts with a high PI. Such grafts should be carefully assessed even when there is no other indicator of a suboptimal graft function clinically, by either EKG or echocardiography. The authors suggest that intra-operative use of TTF measurement of arterial aortocoronary bypass grafts should become the standard of care. machine is wrong, I know I did a good graft. It is just one way to check before you leave the operating room.
Dr D'ancona: I agree with you. And so the last question. How many in this room routinely use any means of intra-operative graft patency verification? Dr F. Beyersdorf (Freiburg, Germany): Nobody? No. So raise your arms, who is using this flow measurement?
(Show of hands).
Dr Beyersdorf: Thank you very much, and I just remind you that coronary artery bypass surgery is one of the only surgeries on vessels which is not controlled in the OR by angiography, for reasons we all know. So at least the flow measurement is one of the quality assurance measurements we can do, and therefore I am also a great proponent for using that even though there are, of course, many problems with the distal flow, the distal vascular bed and so on, but, still, it is something that we can check when we are doing the graft.
